FDA Investigator Christopher M Jenner

Christopher M Jenner has inspections in 3 countries as of 01 Nov 2023. Christopher M Jenner has collaborated with a combinined 3159 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
54
Last Inspection Date:
01 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, India, Mexico
Co-Investigator(s):
Ademola O Daramola, Alan M Barker, Alan P Kurtzberg, Amalia C Himaya, Amanda L Fyles, Amir Alavi, Ana P Pineda Zavaleta, Andrea J Schmidt, Andrea S Heise, Angela E Glenn, Angela Shepas, Armando Chavez, MS, Atul J Agrawal, Binh T Nguyen, Brenda Chavez, Brian P Hendrickson, Bruce W Benware, Bryan A Galvez, Bryan L Mcguckin, Capri R Woolridge, Carla J Lundi, Carla M Fernandez Borges, Carlos Chavez, Carol Henderson, Caroline H Le, Carr Sharpe, Carrie A Hughes, Caryn M Mcnab, Cassandra L Abellard, Cecilia H Kieu, Charles L Larson, Cheryl D Mccall, Christine L Williams, Christopher D Washington, Ciara J Bajulai Austin, Daniel J Lahar, Darren S Brown, Debra I Love, Devon O Seymour, Diana M Rand, Diane R Weidley, Djamila Harouaka, Dogbeda F Mackenzie, Dongping Dai, PhD, Dustin M James, Edith M Gonzalez, Edward P Potter, Elizabeth P Mayer, Eric R Holm, Erika V Butler, Finn A Slizza, Garciam, Garrad R Poole, Gary C Pecic, Gavin T Cua, Gerard T Schneider, Ginger M Sykes, Greg K Keshishyan, Gunneet Kaur, Harry A Wilson, Heriberto Negron Rivera, Hinh T Nguyen, Holly J Smith, Hung V Le, Hung Van Le, Jacob W Reynolds, James P Stallings, Jamie L Dion, Jeffery A Johnson, Jeffrey P Raimondi, Jennifer A Robinson, Jennifer M Heitz, Jennifer M Pouget, Jessica I Newman, Joey V Quitania, Jogy George, John A Daubenspeck, John A Gonzalez, Jorge L Bertran, Jose E Melendez, DDC, Joseph M Allen, Judy C Nepsa, June P Page, Ka L Wong, Karen M Labounty, Kari M Johansen, Kate L Allen, Katherine Szestypalow, Kelley, Kelvin Cheung, Kelvin X Sanders, Kent C Faul, Kham Phommachanh, Khumo A Phake, Kibily D Dembele, Kimberley A Hoefen, Kristin M Abaonza, Langer, Laura A Munsterman, Laurimer Kuilan Torres, Liming Zhang, Linda F Murphy, Linda Thai, Lisa M Schultz, Lucas B Leake, Marcus F Yambot, Margaret M Annes, Margo Cl Jones, Marion W Nadeau, Mary Jeanet Mcgarry, Matthew J Hansen, Matthew J Johnson, Matthew R Dionne, Meaghan M Rabideau, Melinda Lee, Michael A Charles, Michael D Garcia, Michael J Kuchta, Michael R Goga, Michael T Cyrus, Michelle J Hines, Mihaly S Ligmond, Nadeem I Chaudhry, Nancy G Schmidt, Natalie J Ayoub, Nayan J Patel, Nianna C Burns, Nianna M Capalia, Nicholas Fragedakis, Nicholas J Hunt, Nicholas L Hunt, Oluwaseyi Ojinni, Patricia A Brown, Patricia P Wrona, Rabin N Ghoshal, Rafael Nevarez Nieves, Randall N Johnson, Richard A Abate, Richard T Jensen, Richmond K Yip, Ricki A Chase, Ricki Achase Off, Roger F Zabinski, Rowena S Nguyen, Saied A Asbagh, Samantha E Rafferty, Sangeeta M Khurana, PhD, Santiago Gallardo Johnson, Sara Jdent Acosta, Scott K Zika, Scott N Lim, Sean P Desbrow, Selene T Torres, Sonia R Peterson, Sri Ramakrishnaiah Yellela, State Agency, Stephanie A Slater, MS, Stephen T Hansen, Sumit Sen, Taichun Qin, PhD, Tara L Stockton, Thanh M Andrews, Theresa Kirkham (NMI), Tiara M Brown, Timothy T Kapsala, Tracey T Duong, Truong Xuan Nguyen (Andy), Uduak M Inokon, Uttaniti Limchumroon (Tom), Vashti E Bocker, Vioela J Caze, Virgilio F Pacio, CSO, Walden H Lee, William J Leonard, Yen Tso Kuo, Yi Lin, Yiyue Zhang (nmi), PhD, Yvette E Guillermo, Yvonne T Lacour, Zachary A Bogorad, Zachary L Miller, Zachary L Stamm

Christopher M Jenner's Documents

Publish Date Document Type Title
June, 2019 FDA 483 Precision Science, Inc. - Form 483, 2019-06-21
August, 2022 FDA 483 West Pharmaceutical Services AZ, Inc - Form 483, 2022-08-19
March, 2019 FDA 483 Customceutical Compounding - Form 483, 2019-03-08
November, 2021 FDA 483 Response RLC Labs Inc. - Form 483R, 2021-12-09
March, 2018 FDA 483 Cardinal Health 414, LLC - Form 483, 2018-03-16
May, 2018 FDA 483 kdc/one Chatsworth, Inc. - Form 483, 2018-05-25
August, 2021 FDA 483 First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy - Form 483, 2021-08-11
June, 2022 FDA 483 TOLMAR 1201 Cornerstone LLC - Form 483, 2022-06-17
September, 2022 FDA 483 First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy - Form 483, 2022-09-12
May, 2018 EIR kdc/one Chatsworth, Inc. - EIR, 2018-05-25
December, 2017 FDA 483 Cody Laboratories, Inc. - Form 483, 2017-12-08
November, 2021 FDA 483 Specialty Process Labs - Form 483, 2021-11-19
November, 2021 FDA 483 RLC Labs Inc. - Form 483, 2021-11-04
December, 2017 EIR Cody Laboratories, Inc. - EIR, 2017-12-08
February, 2022 FDA 483 Central Admixture Pharmacy Services, Inc. - Form 483, 2022-02-25
February, 2018 FDA 483 Botanic Beauty Products, Inc. - Form 483, 2018-02-02
September, 2021 FDA 483 Signature Formulations LLC - Form 483, 2021-09-30
May, 2018 FDA 483 Response kdc/one Chatsworth, Inc. - Form 483R, 2018-05-31
September, 2019 FDA 483 Ortin Laboratories Ltd Unit II - Form 483, 2019-09-06
March, 2020 FDA 483 RLC Labs Inc. - Form 483, 2020-03-05
February, 2019 FDA 483 Specialty Formulations and Manufacturing LLC - Form 483, 2019-02-20
October, 2017 EIR Actavis Laboratories UT, Inc. - EIR, 2017-10-25
September, 2018 FDA 483 Thatcher Company - Form 483, 2018-09-18
September, 2019 EIR Annora Pharma Private Limited - EIR, 2019-09-13
January, 2020 EIR Nexgen Pharma, Inc. - EIR, 2020-01-31
October, 2018 FDA 483 Foothills Professional Pharmacy, LTD - Form 483, 2018-10-24
September, 2022 FDA 483 Precision Science, Inc. - Form 483, 2022-09-23
June, 2021 FDA 483 Airgas USA, LLC - Form 483, 2021-06-17
January, 2020 FDA 483 Island Kinetics, Inc. d.b.a. CoValence Laboratories - Form 483, 2020-01-06
April, 2019 EIR Sterigenics Radiation Technologies, LLC - EIR, 2019-04-26
December, 2019 FDA 483 Mayo Clinic PET Radiochemistry Facility - Form 483, 2019-12-12
December, 2018 FDA 483 SIDDHA FLOWER ESSENCES - Form 483, 2018-12-12

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more